REFERENCES
2. Nilsson PM, Boutouyrie P, Laurent S. Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension. 2009;54:3-10.
3. Bruno RM, Nilsson PM, Engström G, et al. Early and supernormal vascular aging: clinical characteristics and association with incident cardiovascular events. Hypertension. 2020;76:1616-24.
4. Herzog MJ, Müller P, Lechner K, et al. Arterial stiffness and vascular aging: mechanisms, prevention, and therapy. Signal Transduct Target Ther. 2025;10:282.
5. van der Linden J, Stefens SJM, Heredia-Genestar JM, et al. Ercc1 DNA repair deficiency results in vascular aging characterized by VSMC phenotype switching, ECM remodeling, and an increased stress response. Aging Cell. 2024;23:e14126.
6. Beeche C, Zhao B, Tavolinejad H, et al. Early vascular aging determined by 3-dimensional aortic geometry: genetic determinants and clinical consequences. Circulation. 2025;152:748-61.
7. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation. 2003;107:490-7.
8. Donato AJ, Machin DR, Lesniewski LA. Mechanisms of dysfunction in the aging vasculature and role in age-related disease. Circ Res. 2018;123:825-48.
9. Fleenor BS, Carlini NA, Ouyang A, Du B, Harber MP. Greater aortic perivascular adipose tissue density is associated with aging, aortic stiffness, and central blood pressure in humans. J Appl Physiol. 2023;134:703-9.
10. Safar ME, Nilsson PM, Blacher J, Mimran A. Pulse pressure, arterial stiffness, and end-organ damage. Curr Hypertens Rep. 2012;14:339-44.
11. Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension. 2004;43:163-8.
12. van Sloten TT, Protogerou AD, Henry RM, Schram MT, Launer LJ, Stehouwer CD. Association between arterial stiffness, cerebral small vessel disease and cognitive impairment: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2015;53:121-30.
13. 2023 Causes of Death Collaborators. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the global burden of disease study 2023. Lancet. 2025;406:1811-72.
14. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular disease. Circulation. 2003;107:139-46.
15. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-406.
16. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-5.
17. Van Bortel LM, Laurent S, Boutouyrie P, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30:445-8.
18. Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15:505-22.
19. Salvioli S, Basile MS, Bencivenga L, et al. Biomarkers of aging in frailty and age-associated disorders: state of the art and future perspective. Ageing Res Rev. 2023;91:102044.
20. Wang W, Yan Y, Guo Z, et al.; Suboptimal Health Study Consortium and European Association for Predictive. All around suboptimal health - a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine. EPMA J. 2021;12:403-33.
22. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25:44-56.
23. Johnson KW, Torres Soto J, Glicksberg BS, et al. Artificial intelligence in cardiology. J Am Coll Cardiol. 2018;71:2668-79.
24. Yang XY, Li YM, Wang JY, Jia YH, Yi Z, Chen M. Utilizing multimodal artificial intelligence to advance cardiovascular diseases. Precis Clin Med. 2025;8:pbaf016.
25. North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012;110:1097-108.
26. Moor M, Banerjee O, Abad ZSH, et al. Foundation models for generalist medical artificial intelligence. Nature. 2023;616:259-65.
27. Bommasani R, Hudson DA, Adeli E, et al. On the opportunities and risks of foundation models. arXiv. 2022;arXiv:2108.07258.
28. Shao Q, Ndzie Noah ML, Golubnitschaja O, Zhan X. Mitochondrial medicine: “from bench to bedside” 3PM-guided concept. EPMA J. 2025;16:239-64.
29. Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary calcium score and cardiovascular risk. J Am Coll Cardiol. 2018;72:434-47.
30. Willemink MJ, Vliegenthart R, Takx RA, et al. Coronary artery calcification scoring with state-of-the-art CT scanners from different vendors has substantial effect on risk classification. Radiology. 2014;273:695-702.
31. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459-67.
32. Lorenz MW, Polak JF, Kavousi M, et al.; PROG-IMT Study Group. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet. 2012;379:2053-62.
33. Bianchini E, Guala A, Golemati S, et al. The ultrasound window into vascular ageing: a technology review by the VascAgeNet COST action. J Ultrasound Med. 2023;42:2183-213.
34. Spronck B, Terentes-Printzios D, Avolio AP, et al. 2024 recommendations for validation of noninvasive arterial pulse wave velocity measurement devices. Hypertension. 2024;81:183-92.
35. Harloff A, Mirzaee H, Lodemann T, et al. Determination of aortic stiffness using 4D flow cardiovascular magnetic resonance - a population-based study. J Cardiovasc Magn Reson. 2018;20:43.
36. Poplin R, Varadarajan AV, Blumer K, et al. Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning. Nat Biomed Eng. 2018;2:158-64.
37. Nusinovici S, Rim TH, Li H, et al. Application of a deep-learning marker for morbidity and mortality prediction derived from retinal photographs: a cohort development and validation study. Lancet Healthy Longev. 2024;5:100593.
39. Lu AT, Quach A, Wilson JG, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging. 2019;11:303-27.
40. Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging. 2018;10:573-91.
41. Yousefi PD, Suderman M, Langdon R, Whitehurst O, Davey Smith G, Relton CL. DNA methylation-based predictors of health: applications and statistical considerations. Nat Rev Genet. 2022;23:369-83.
42. Liang R, Tang Q, Chen J, Zhu L. Epigenetic clocks: beyond biological age, using the past to predict the present and future. Aging Dis. 2024;16:3520-45.
43. Argentieri MA, Xiao S, Bennett D, et al. Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations. Nat Med. 2024;30:2450-60.
44. Ding Y, Zuo Y, Zhang B, et al. Comprehensive human proteome profiles across a 50-year lifespan reveal aging trajectories and signatures. Cell. 2025;188:5763-5784.e26.
45. Raffield LM, Dang H, Pratte KA, et al.; NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium. Comparison of proteomic assessment methods in multiple cohort studies. Proteomics. 2020;20:e1900278.
46. Jasbi P, Nikolich-Žugich J, Patterson J, et al. Targeted metabolomics reveals plasma biomarkers and metabolic alterations of the aging process in healthy young and older adults. Geroscience. 2023;45:3131-46.
47. Kočar E, Šket R, Vasle AH, et al. Measuring biological age: insights from omics studies. Ageing Res Rev. 2026;114:102988.
48. Emechebe U, Nelson JW, Alkayed NJ, Kaul S, Adey AC, Barnes AP. Age-dependent transcriptional alterations in cardiac endothelial cells. Physiol Genomics. 2021;53:295-308.
49. Golubnitschaja O. How to use an extensive Flammer syndrome phenotyping for a holistic protection against health-to-disease transition - facts and practical recommendations. EPMA J. 2025;16:535-9.
50. Nie G, Zhao Q, Tang G, Li Y, Hong S. Artificial intelligence-derived photoplethysmography age as a digital biomarker for cardiovascular health. Commun Med. 2025;5:481.
51. Zhao Q, Nie G, Nie W, Tang G, Hong S. Artificial intelligence-derived vascular age from photoplethysmography: a novel digital biomarker for cardiovascular health. Eur Heart J. 2025;46:ehaf784.4449.
52. Sheikh AB, Sobotka PA, Garg I, et al. Blood pressure variability in clinical practice: past, present and the future. J Am Heart Assoc. 2023;12:e029297.
53. Kario K. Morning surge in blood pressure and cardiovascular risk: evidence and perspectives. Hypertension. 2010;56:765-73.
54. Drawz PE, Pajewski NM, Bates JT, et al. Effect of intensive versus standard clinic-based hypertension management on ambulatory blood pressure: results from the SPRINT (systolic blood pressure intervention trial) ambulatory blood pressure study. Hypertension. 2017;69:42-50.
55. Guimarães P, Keller A, Böhm M, et al. Artificial intelligence-derived risk prediction: a novel risk calculator using office and ambulatory blood pressure. Hypertension. 2025;82:46-56.
56. Xie H, Yang L, Jiang B, Huang Z, Lin Y. State-of-the-art wearable sensors for cardiovascular health: a review. NPJ Cardiovasc Health. 2025;2:53.
57. Task Force of the European Society of Cardiology the North American Society of Pacing Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93:1043-65.
58. Goldstein DS, Bentho O, Park MY, Sharabi Y. Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes. Exp Physiol. 2011;96:1255-61.
59. Hillebrand S, Gast KB, de Mutsert R, et al. Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression. Europace. 2013;15:742-9.
60. Theurl F, Schreinlechner M, Sappler N, et al. Smartwatch-derived heart rate variability: a head-to-head comparison with the gold standard in cardiovascular disease. Eur Heart J Digit Health. 2023;4:155-64.
61. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318-27.
62. Hong J, Nandi M, Charlton PH, Alastruey J. Noninvasive hemodynamic indices of vascular aging: an in silico assessment. Am J Physiol Heart Circ Physiol. 2023;325:H1290-303.
63. Doherty C, Baldwin M, Keogh A, Caulfield B, Argent R. Keeping pace with wearables: a living umbrella review of systematic reviews evaluating the accuracy of consumer wearable technologies in health measurement. Sports Med. 2024;54:2907-26.
64. Jamieson A, Chico TJA, Jones S, Chaturvedi N, Hughes AD, Orini M. A guide to consumer-grade wearables in cardiovascular clinical care and population health for non-experts. NPJ Cardiovasc Health. 2025;2:44.
65. Boonstra MJ, Weissenbacher D, Moore JH, Gonzalez-Hernandez G, Asselbergs FW. Artificial intelligence: revolutionizing cardiology with large language models. Eur Heart J. 2024;45:332-45.
66. Pons E, Braun LM, Hunink MG, Kors JA. Natural language processing in radiology: a systematic review. Radiology. 2016;279:329-43.
67. Ferreira Santos J, Ladeiras-Lopes R, Leite F, Dores H. Applications of large language models in cardiovascular disease: a systematic review. Eur Heart J Digit Health. 2025;6:540-53.
68. Ferreira Santos J, Dores H. Large language models in cardiovascular prevention: a narrative review and governance framework. Diagnostics. 2026;16:390.
69. Gao Z, Liu X, Kang Y, et al. Improving the prognostic evaluation precision of hospital outcomes for heart failure using admission notes and clinical tabular data: multimodal deep learning model. J Med Internet Res. 2024;26:e54363.
70. Sarmun R, Kabir S, Prithula J, et al. Enhancing intima-media complex segmentation with a multi-stage feature fusion-based novel deep learning framework. Eng Appl Artif Intell. 2024;133:108050.
71. Kim S, Park EA, Ahn C, et al. Performance of fully automated deep-learning-based coronary artery calcium scoring in ECG-gated calcium CT and non-gated low-dose chest CT. Eur Radiol. 2025;35:7084-95.
72. Attia ZI, Friedman PA, Noseworthy PA, et al. Age and sex estimation using artificial intelligence from standard 12-lead ECGs. Circ Arrhythm Electrophysiol. 2019;12:e007284.
73. Rawlani M, Ieki H, Binder C, et al. Artificial intelligence prediction of age from echocardiography as a marker for cardiovascular disease. npj Digit Med. 2025;8:688.
74. Lima EM, Ribeiro AH, Paixão GMM, et al. Deep neural network-estimated electrocardiographic age as a mortality predictor. Nat Commun. 2021;12:5117.
75. Linardos A, Kushibar K, Walsh S, Gkontra P, Lekadir K. Federated learning for multi-center imaging diagnostics: a simulation study in cardiovascular disease. Sci Rep. 2022;12:3551.
77. Avsec Ž, Agarwal V, Visentin D, et al. Effective gene expression prediction from sequence by integrating long-range interactions. Nat Methods. 2021;18:1196-203.
78. Rasmy L, Xiang Y, Xie Z, Tao C, Zhi D. Med-BERT: pretrained contextualized embeddings on large-scale structured electronic health records for disease prediction. npj Digit Med. 2021;4:86.
79. Stahlschmidt SR, Ulfenborg B, Synnergren J. Multimodal deep learning for biomedical data fusion: a review. Brief Bioinform. 2022;23:bbab569.
80. Schouten D, Nicoletti G, Dille B, et al. Navigating the landscape of multimodal AI in medicine: a scoping review on technical challenges and clinical applications. Med Image Anal. 2025;105:103621.
81. Soenksen LR, Ma Y, Zeng C, et al. Integrated multimodal artificial intelligence framework for healthcare applications. npj Digit Med. 2022;5:149.
82. Zhang S, Xu Y, Usuyama N, et al. A multimodal biomedical foundation model trained from fifteen million image-text pairs. NEJM AI. 2025;2:AIoa2400640.
83. Nielsen C, Souza R, Wilms M, Forkert ND. Foundation model-driven distributed learning for enhanced retinal age prediction. J Am Med Inform Assoc. 2024;31:2550-9.
84. Acosta JN, Falcone GJ, Rajpurkar P, Topol EJ. Multimodal biomedical AI. Nat Med. 2022;28:1773-84.
85. Zhang K, Zhou R, Adhikarla E, et al. A generalist vision-language foundation model for diverse biomedical tasks. Nat Med. 2024;30:3129-41.
86. Singhal K, Azizi S, Tu T, et al. Large language models encode clinical knowledge. Nature. 2023;620:172-80.
87. Zakka C, Shad R, Chaurasia A, et al. Almanac - retrieval-augmented language models for clinical medicine. NEJM AI. 2024;1:AIoa2300068.
88. Salih A, Boscolo Galazzo I, Gkontra P, et al. Explainable artificial intelligence and cardiac imaging: toward more interpretable models. Circ Cardiovasc Imaging. 2023;16:e014519.
89. Omar M, Sorin V, Collins JD, et al. Multi-model assurance analysis showing large language models are highly vulnerable to adversarial hallucination attacks during clinical decision support. Commun Med. 2025;5:330.
90. Asgari E, Montaña-Brown N, Dubois M, et al. A framework to assess clinical safety and hallucination rates of LLMs for medical text summarisation. npj Digit Med. 2025;8:274.
91. Hadida Barzilai D, Sudri K, Goshen G, et al. Randomized controlled trials evaluating artificial intelligence in cardiovascular care: a systematic review. JACC Adv. 2025;4:102152.
92. Mossavarali S, Vaezi A, Gholami Z, et al. Determinants of artificial intelligence electrocardiogram-derived age and its association with cardiovascular events and mortality: a systematic review and meta-analysis. npj Digit Med. 2025;8:322.
93. Pedroso AF, Khera R. Leveraging AI-enhanced digital health with consumer devices for scalable cardiovascular screening, prediction, and monitoring. NPJ Cardiovasc Health. 2025;2:34.
94. Cavero-Redondo I, Saz-Lara A, Martínez-García I, Otero-Luis I, Martínez-Rodrigo A. Validation of an early vascular aging construct model for comprehensive cardiovascular risk assessment using external risk indicators for improved clinical utility: data from the EVasCu study. Cardiovasc Diabetol. 2024;23:33.
95. Abedi A, Verma A, Jain D, et al. AI-driven real-time monitoring of cardiovascular conditions with wearable devices: scoping review. JMIR Mhealth Uhealth. 2025;13:e73846.
96. Huang G, Chen X, Liao C. AI-driven wearable bioelectronics in digital healthcare. Biosensors. 2025;15:410.
97. Noci F, Capodici A, Nuti S, Passino C, Emdin M, Giannoni A. Wearable technologies to predict and prevent and heart failure hospitalizations: a systematic review. Eur Heart J Digit Health. 2025;6:868-77.
98. Oikonomou EK, Spatz ES, Suchard MA, Khera R. Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials. Lancet Digit Health. 2022;4:e796-805.
99. Wang TW, Syu JY, Chu HW, et al. Intelligent bio-impedance system for personalized continuous blood pressure measurement. Biosensors. 2022;12:150.
100. Ucdal M, Yurtsever K, Yildiz P, Akalin A, Mert KU, Guven GS. Comparison of artificial intelligence models and human experts in managing dyslipidemia: assessment of adherence to clinical guidelines. Cureus. 2025;17:e91363.
101. Costa F, Gomez Doblas JJ, Díaz Expósito A, et al. Artificial intelligence in cardiovascular pharmacotherapy: applications and perspectives. Eur Heart J. 2025;46:3616-27.
102. Li C, Wong C, Zhang S, et al. LLaVA-Med: training a large language-and-vision assistant for biomedicine in one day. arXiv 2023;arXiv:2306.00890.
103. Hannun AY, Rajpurkar P, Haghpanahi M, et al. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med. 2019;25:65-9.
104. Liu X, Cruz Rivera S, Moher D, Calvert MJ, Denniston AK; SPIRIT-AI and CONSORT-AI Working Group. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Lancet Digit Health. 2020;2:e537-48.
105. Veneziano FA, Cocco N, Veneziano R. Artificial intelligence in interventional cardiology: current applications and future clinical integration. Vessel Plus. 2025;9:3.
106. van Kolfschooten H. The AI cycle of health inequity and digital ageism: mitigating biases through the EU regulatory framework on medical devices. J Law Biosci. 2023;10:lsad031.
107. Chen RJ, Wang JJ, Williamson DFK, et al. Algorithmic fairness in artificial intelligence for medicine and healthcare. Nat Biomed Eng. 2023;7:719-42.
108. Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366:447-53.
109. Alderman JE, Palmer J, Laws E, et al. Tackling algorithmic bias and promoting transparency in health datasets: the STANDING Together consensus recommendations. Lancet Digit Health. 2025;7:e64-88.
111. Lashkarinia SS, Lee AWC, Baptiste TMG, et al. Representation of women in cardiovascular disease management: a systematic analysis of ESC guidelines. Open Heart. 2025;12:e003320.
112. St Pierre SR, Kaczmarski B, Peirlinck M, Kuhl E. Sex-specific cardiovascular risk factors in the UK Biobank. Front Physiol. 2024;15:1339866.
113. Mitchell GF, Rong J, Larson MG, et al. Vascular age assessed from an uncalibrated, noninvasive pressure waveform by using a deep learning approach: the AI-vascularage model. Hypertension. 2024;81:193-201.
114. Singh P, Hu T, Hoori A, Al-Kindi S, Wilson DL, Rajagopalan S. Sex-specific cardiovascular risk prediction using AI-derived epicardial adipose tissue measurements on CT calcium scoring exams. Am J Prev Cardiol. 2026;25:101367.
115. De Martin Topranin V, Wiig-Fisketjøn A, Botten E, Dalen H, Langaas M, Bye A. Sex-specific cardiovascular disease risk prediction using statistical learning and explainable artificial intelligence: the HUNT study. Eur J Prev Cardiol. 2026;33:2400-11.
116. Romero LGL. CARAMEL: retrospective study for personalized risk assessment of cardiovascular disease in menopausal and perimenopausal women using real world data (CARAMEL RS). Available from: https://clinicaltrials.gov/study/NCT06999317 [accessed 12 October 2026].
117. Singh R, Bapna M, Diab AR, Ruiz ES, Lotter W. How AI is used in FDA-authorized medical devices: a taxonomy across 1,016 authorizations. npj Digit Med. 2025;8:388.
118. U.S. Food and Drug Administration. List of artificial intelligence-enabled medical devices. Available from: https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices [accessed 12 October 2026].
119. Warraich H, Tazbaz T, Califf RM. Regulation of artificial intelligence in health care and biomedicine-reply. JAMA. 2025;333:1003-4.
120. Muehlematter UJ, Daniore P, Vokinger KN. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis. Lancet Digit Health. 2021;3:e195-203.
121. Gerke S, Babic B, Evgeniou T, Cohen IG. The need for a system view to regulate artificial intelligence/machine learning-based software as medical device. npj Digit Med. 2020;3:53.
123. Doshi-Velez F, Kim B. Towards a rigorous science of interpretable machine learning. arXiv. 2017;arXiv:1702.08608.
124. Muhammad D, Bendechache M. Unveiling the black box: a systematic review of explainable artificial intelligence in medical image analysis. Comput Struct Biotechnol J. 2024;24:542-60.
125. Loh HW, Ooi CP, Seoni S, Barua PD, Molinari F, Acharya UR. Application of explainable artificial intelligence for healthcare: a systematic review of the last decade (2011-2022). Comput Methods Programs Biomed. 2022;226:107161.
126. Brankovic A, Cook D, Rahman J, et al. Clinician-informed XAI evaluation checklist with metrics (CLIX-M) for AI-powered clinical decision support systems. npj Digit Med. 2025;8:364.
127. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186:243-78.
128. Kalyakulina A, Yusipov I, Moskalev A, Franceschi C, Ivanchenko M. eXplainable artificial intelligence (XAI) in aging clock models. Ageing Res Rev. 2024;93:102144.
129. Strangio A, Leo I, Sabatino J, et al. Is artificial intelligence the new kid on the block? Sustainable applications in cardiology. Vessel Plus. 2024;8:12.
